2000
DOI: 10.1111/j.1572-0241.2000.01828.x
|View full text |Cite
|
Sign up to set email alerts
|

What's good for the goose should be good for the gander-6-MP use in fathers with inflammatory bowel disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0
1

Year Published

2001
2001
2017
2017

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 22 publications
(7 citation statements)
references
References 18 publications
0
6
0
1
Order By: Relevance
“…Most of the concern surrounding the use of AZA/6‐MP has focused on the pregnant woman; however, recently concerns have been raised regarding the risk of pregnancy related complications when the father is or has taken 6‐MP (77,78). In a retrospective review of pregnancy outcome among fathers treated with 6‐MP compared with fathers who had never been treated with 6‐MP, the incidence of pregnancy‐related complications was significantly increased when fathers used 6‐MP within 3 months of conception (78).…”
Section: Medical Therapy During Pregnancymentioning
confidence: 99%
“…Most of the concern surrounding the use of AZA/6‐MP has focused on the pregnant woman; however, recently concerns have been raised regarding the risk of pregnancy related complications when the father is or has taken 6‐MP (77,78). In a retrospective review of pregnancy outcome among fathers treated with 6‐MP compared with fathers who had never been treated with 6‐MP, the incidence of pregnancy‐related complications was significantly increased when fathers used 6‐MP within 3 months of conception (78).…”
Section: Medical Therapy During Pregnancymentioning
confidence: 99%
“…Although this study was congruent with older animal studies and a Danish human study that suggested a similar trend, 39 this study was fiercely criticized for its low statistical power and wide confidence intervals. 40 More importantly, more recent studies failed to duplicate these concerning findings, 4143 and recent ECCO guidelines on reproduction and pregnancy do not recommend the peri-conception discontinuation of thiopurines. 44 …”
Section: Immunomodulatorsmentioning
confidence: 99%
“…Secondly, there were relatively few retrospective studies on the safety of immunomodulators in the pregnant patient with IBD, most of which reported an increased risk for congenital malformations [101]. Most studies were limited by the retrospective nature of the data collection, the small sample size, and the lack of information regarding disease activity in the fathers and comorbidity in the mothers [105]. Most studies were limited by the retrospective nature of the data collection, the small sample size, and the lack of information regarding disease activity in the fathers and comorbidity in the mothers [105].…”
Section: Azathioprine and 6-mercaptopurinementioning
confidence: 99%